From a clinical perspective, NXT2 is a strong candidate gene for male infertility due to azoospermia but the identification of additional patients harboring variants in NXT2 is necessary to firmly establish a clinically valid gene-disease relationship. This evidence concerns the gene NXT2 and Azoospermia.